Max Michael Traeger

Max Michael Traeger

Auto-generated profile, based on publicly available information

Max Michael Traeger

Clinic of Urology University Hospital Freiburg Freiburg Germany

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2017 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
MTMax M. Träger
Max M. Träger
SDSameer A. Dhayat
Sameer A. Dhayat

22 September 2018 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
MTMax Michael Traeger
Max Michael Traeger
JRJan Rehkaemper
Jan Rehkaemper
HUHansjoerg Ullerich
Hansjoerg Ullerich
Konrad SteinestelKonrad Steinestel
Konrad Steinestel
EWEva Wardelmann
Eva Wardelmann
SDSameer Dhayat
Sameer Dhayat

17 September 2025 in BMC Urology
Verified
Journal Article
Open access
PDF file
MTMax Traeger
Max Traeger
TWTabea Walther
Tabea Walther
Jeremy Yuen Chun TeohJeremy Yuen Chun Teoh
Jeremy Yuen Chun Teoh
MWMarcelo Langer Wroclawski
Marcelo Langer Wroclawski
THThomas R.W. Herrmann
Thomas R.W. Herrmann
DSDominik Schoeb
Dominik Schoeb
Background: Up to 50% of patients with benign prostate hyperplasia (BPH) face post-operative complications after transurethral prostate Surgery. This includes nearly 15% of patients suffering from prolonged post-operative pelvic pain (pPPP) consisting of dysuria and prostatodynia for sometimes several months post-surgery. This study elucidates and proposes a definition of the multi-dimensional nature of prolonged post-operative pelvic pain (pPPP) after transurethral prostate surgery by providing real-world data on therapeutic options and their efficacy. Methods: German and international urologic practitioners participated in an online-survey after invitation via social media accounts and newsletters. The survey included questions on the amount of expertise, the therapeutic regimens for prolonged post-operative pelvic pain (pPPP) and the expected therapy outcome. Participation was voluntary and uncompensated. Chi-Square tests and Student’s t-tests were used for descriptive statistics. Results: 67 German urologists participated in a 9-question online Survey. 94,0% treated patients with lower urinary tract symptoms and 85,1% disclosed their therapeutic regime for prolonged post-operative pelvic pain (pPPP). The most common treatments included anti-inflammatory medication (69,6%), anti-cholinergics (53,6%), alpha-blockers (51,8%) and pelvic physiotherapy (50,0%). Over half of the patients responded to the therapeutic approach, but only 5,4% of urologists anticipated full pain relief after one year. These findings are closely aligned with a recent international survey (n=230). Notably, German urologists more frequently prescribed anti-cholinergics (53,6% vs. 28,7%, p = 0,0004), herbal remedies like saw palmetto (25,0% vs. 6,5%, p < 0,0001) and non-pharmacological therapies (82,1% vs. 49,1%, p < 0,0001), but less anti-inflammatory drugs (69,6% vs. 88,7%, p = 0,0003), gabapentin/pregabalin (8,9% vs. 42,2%, p < 0,0001) and opioids (0% vs 5,7%, p = 0,0221). Based on these results a structured definition and therapy plan for prolonged post-operative pelvic pain (pPPP) is proposed. Conclusion: Prolonged post-operative pelvic pain (pPPP) is a common challenge for urologists. Despite various therapeutic options, treatment outcomes and practitioner confidence remain suboptimal. Further research and attention to prolonged post-operative pelvic pain (pPPP) are essential to develop evidence-based guidelines for effective patient management and prevention of chronic pain syndromes.

22 June 2026 in Andrology
Verified
Journal Article
Open access
TMTraeger Max
Traeger Max
GPGloeckler Paulina
Gloeckler Paulina
HJHess Jochen
Hess Jochen
KJKranz Jennifer
Kranz Jennifer
MSMorgenstern Saskia
Morgenstern Saskia
SDSchlager Daniel
Schlager Daniel
Background: The internet, including websites and large language models (LLMs), is an increasingly important information resource for medical patients. However, information quality varies, potentially leading to misinformation. Andrological patients may particularly rely on online sources due to the sensitive nature of their conditions. Objectives: To assess the prevalence and quality of internet research among andrological patients and evaluate common online sources for comprehensibility, readability, and accuracy. Materials and Methods: Patients ( n = 283) at four German andrological centers completed a questionnaire on their online information behavior between November 2022 and October 2023. Common online sources were objectively evaluated using the DISCERN tool and Flesch readability index in 2023. Popular LLMs were also assessed in October 2024 and compared to traditional websites. Results: 67% ( n = 190/283) of andrological patients seek medical information before appointments, primarily using the internet (52%, n = 148/283) and general practitioners (49%, n = 139/283). Patients under 50 predominantly use online sources (60%, n = 74/122). Official medical association websites and Wikipedia are preferred, but 30% also use commercial sites ( n = 91/283). In general, most common websites and LLMs provide sufficient information but lack easy comprehensibility and readability. Discussion: The study highlights the widespread use of online resources by andrological patients and emphasizes the importance of high‐quality medical information. While online tools show promise, the value of physician–patient communication remains irreplaceable and cannot be replaced by chatting with LLMs. Conclusion: Official medical association should provide accurate and easily understood information for andrological patients. Efforts to improve the online media literacy and communication skills of medical personnel are necessary. Trial Registration Number: The study was registered in the German WHO primary registry, the German Clinical Trials Register (DRKS) (Number: DRKS00029651).